Skip to main content
Top
Published in: BMC Surgery 1/2017

Open Access 01-12-2017 | Research article

Therapeutic effects of flurbiprofen axetil on mesenteric traction syndrome: randomized clinical trial

Authors: Hidemasa Takahashi, Dai Shida, Kyoko Tagawa, Ryo Iwamoto, Makoto Arita, Hiroyuki Arai, Takeo Suzuki

Published in: BMC Surgery | Issue 1/2017

Login to get access

Abstract

Background

This study aimed to reveal the appropriate timing for the intravenous administration of flurbiprofen axetil for preventing mesenteric traction syndrome (MTS), caused by prostacyclin release.

Methods

In this prospective, randomized, clinical study, forty-five patients who were undergoing elective surgery for colorectal cancer via laparotomy were enrolled. Patients were randomly divided into 3 groups: a preoperative group (n = 16) receiving flurbiprofen axetil directly before surgery; a post-MTS group (n = 14) receiving following MTS onset; and a control group (n = 15) who were not administered flurbiprofen axetil. 6-keto-PGF1α, a stable metabolite of prostacyclin, levels were measured and mean blood pressures were recorded.

Results

In the preoperative group, 6-keto-PGF1α levels did not increase, blood pressure levels did not decrease, and no facial flushing was observed. In both the post-MTS and control groups, 6-keto-PGF1α levels increased markedly after mesenteric traction and blood pressure decreased significantly. The post-MTS group exhibited a faster decreasing trend in 6-keto-PGF1α levels and quick restore of the mean blood pressure, and the use of vasopressors and phenylephrine were lower than that in the control group.

Conclusions

Even therapeutic administration of flurbiprofen axetil after the onset of MTS has also effects on MTS by suppressing prostacyclin production.

Trial registration

Clinical trial number: UMIN000009111. (Registered 14 October 2012)
Literature
1.
go back to reference Tassoudis V, Vretzakis G, Petsiti A, Stamatiou G, Bouzia K, Melekos M, Tzovaras G. Impact of intraoperative hypotension on hospital stay in major abdominal surgery. J Anesth. 2011;25(4):492–9.CrossRefPubMed Tassoudis V, Vretzakis G, Petsiti A, Stamatiou G, Bouzia K, Melekos M, Tzovaras G. Impact of intraoperative hypotension on hospital stay in major abdominal surgery. J Anesth. 2011;25(4):492–9.CrossRefPubMed
2.
go back to reference Monk TG, Saini V, Weldon BC, Sigl JC. Anesthetic management and one-year mortality after noncardiac surgery. Anesth Analg. 2005;100(1):4–10.CrossRefPubMed Monk TG, Saini V, Weldon BC, Sigl JC. Anesthetic management and one-year mortality after noncardiac surgery. Anesth Analg. 2005;100(1):4–10.CrossRefPubMed
3.
go back to reference Seltzer JL, Ritter DE, Starsnic MA, Marr AT. The hemodynamic response to traction on the abdominal mesentery. Anesthesiology. 1985;63(1):96–9.CrossRefPubMed Seltzer JL, Ritter DE, Starsnic MA, Marr AT. The hemodynamic response to traction on the abdominal mesentery. Anesthesiology. 1985;63(1):96–9.CrossRefPubMed
4.
go back to reference Seltzer JL, Goldberg ME, Larijani GE, Ritter DE, Starsnic MA, Stahl GL, Lefer AM. Prostacyclin mediation of vasodilation following mesenteric traction. Anesthesiology. 1988;68(4):514–8.CrossRefPubMed Seltzer JL, Goldberg ME, Larijani GE, Ritter DE, Starsnic MA, Stahl GL, Lefer AM. Prostacyclin mediation of vasodilation following mesenteric traction. Anesthesiology. 1988;68(4):514–8.CrossRefPubMed
5.
go back to reference Gottlieb A, Skrinska VA, O'Hara P, Boutros AR, Melia M, Beck GJ. The role of prostacyclin in the mesenteric traction syndrome during anesthesia for abdominal aortic reconstructive surgery. Ann Surg. 1989;209(3):363–7.CrossRefPubMedPubMedCentral Gottlieb A, Skrinska VA, O'Hara P, Boutros AR, Melia M, Beck GJ. The role of prostacyclin in the mesenteric traction syndrome during anesthesia for abdominal aortic reconstructive surgery. Ann Surg. 1989;209(3):363–7.CrossRefPubMedPubMedCentral
7.
go back to reference Brinkmann A, Seeling W, Wolf CF, Kneitinger E, Schonberger C, Vogt N, Orend KH, Buchler M, Radermacher P, Georgieff M. Vasopressor hormone response following mesenteric traction during major abdominal surgery. Acta Anaesthesiol Scand. 1998;42(8):948–56.CrossRefPubMed Brinkmann A, Seeling W, Wolf CF, Kneitinger E, Schonberger C, Vogt N, Orend KH, Buchler M, Radermacher P, Georgieff M. Vasopressor hormone response following mesenteric traction during major abdominal surgery. Acta Anaesthesiol Scand. 1998;42(8):948–56.CrossRefPubMed
8.
go back to reference Takahashi H, Shida D, Tagawa K, Suzuki T. Hemodynamics of mesenteric traction syndrome measured by FloTrac sensor. J Clin Anesth. 2016;30:46–50.CrossRefPubMed Takahashi H, Shida D, Tagawa K, Suzuki T. Hemodynamics of mesenteric traction syndrome measured by FloTrac sensor. J Clin Anesth. 2016;30:46–50.CrossRefPubMed
9.
go back to reference Cryer B, Feldman M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med. 1998;104(5):413–21.CrossRefPubMed Cryer B, Feldman M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med. 1998;104(5):413–21.CrossRefPubMed
10.
go back to reference Fujimoto Y, Nomura Y, Hirakawa K, Hotta A, Nakamoto A, Yoshikawa N, Ohira N, Tatekawa S. Flurbiprofen axetil provides a prophylactic benefit against mesenteric traction syndrome associated with remifentanil infusion during laparotomy. J Anesth. 2012;26(4):490–5.CrossRefPubMed Fujimoto Y, Nomura Y, Hirakawa K, Hotta A, Nakamoto A, Yoshikawa N, Ohira N, Tatekawa S. Flurbiprofen axetil provides a prophylactic benefit against mesenteric traction syndrome associated with remifentanil infusion during laparotomy. J Anesth. 2012;26(4):490–5.CrossRefPubMed
11.
go back to reference Takada M, Taruishi C, Sudani T, Suzuki A, Iida H. Intravenous flurbiprofen axetil can stabilize the hemodynamic instability due to mesenteric traction syndrome--evaluation with continuous measurement of the systemic vascular resistance index using a FloTrac(R) sensor. J Cardiothorac Vasc Anesth. 2013;27(4):696–702.CrossRefPubMed Takada M, Taruishi C, Sudani T, Suzuki A, Iida H. Intravenous flurbiprofen axetil can stabilize the hemodynamic instability due to mesenteric traction syndrome--evaluation with continuous measurement of the systemic vascular resistance index using a FloTrac(R) sensor. J Cardiothorac Vasc Anesth. 2013;27(4):696–702.CrossRefPubMed
12.
go back to reference Tohno M, Konishi Y, Kojima H, Sakai Y, Kawahara K, Horiba M: [Parmacokinetics and metabolic studies of LFP83 in man after the single and repeated intravenous administration]. Kiso to Rinsho 1992, 26(9):3907–3921. Tohno M, Konishi Y, Kojima H, Sakai Y, Kawahara K, Horiba M: [Parmacokinetics and metabolic studies of LFP83 in man after the single and repeated intravenous administration]. Kiso to Rinsho 1992, 26(9):3907–3921.
13.
go back to reference Takahashi H, Shida D, Tagawa K, Suzuki T: [The preventive effect of flurbiprofen on preventing mesenteric traction syndrome]. Masui 2013, 62(3):309–314. Takahashi H, Shida D, Tagawa K, Suzuki T: [The preventive effect of flurbiprofen on preventing mesenteric traction syndrome]. Masui 2013, 62(3):309–314.
14.
go back to reference Shida D, Tagawa K, Inada K, Nasu K, Seyama Y, Maeshiro T, Miyamoto S, Inoue S, Umekita N. Enhanced recovery after surgery (ERAS) protocols for colorectal cancer in Japan. BMC Surg. 2015;15:90.CrossRefPubMedPubMedCentral Shida D, Tagawa K, Inada K, Nasu K, Seyama Y, Maeshiro T, Miyamoto S, Inoue S, Umekita N. Enhanced recovery after surgery (ERAS) protocols for colorectal cancer in Japan. BMC Surg. 2015;15:90.CrossRefPubMedPubMedCentral
15.
go back to reference Shida D, Wakamatsu K, Tanaka Y, Yoshimura A, Kawaguchi M, Miyamoto S, Tagawa K. The postoperative patient-reported quality of recovery in colorectal cancer patients under enhanced recovery after surgery using QoR-40. BMC Cancer. 2015;15:799.CrossRefPubMedPubMedCentral Shida D, Wakamatsu K, Tanaka Y, Yoshimura A, Kawaguchi M, Miyamoto S, Tagawa K. The postoperative patient-reported quality of recovery in colorectal cancer patients under enhanced recovery after surgery using QoR-40. BMC Cancer. 2015;15:799.CrossRefPubMedPubMedCentral
16.
go back to reference Nomura Y, Funai Y, Fujimoto Y, Hori N, Hirakawa K, Hotta A, Nakamoto A, Yoshikawa N, Ohira N, Tatekawa S. Remifentanil increases the incidence of mesenteric traction syndrome: preliminary randomized controlled trial. J Anesth. 2010;24(5):669–74.CrossRefPubMed Nomura Y, Funai Y, Fujimoto Y, Hori N, Hirakawa K, Hotta A, Nakamoto A, Yoshikawa N, Ohira N, Tatekawa S. Remifentanil increases the incidence of mesenteric traction syndrome: preliminary randomized controlled trial. J Anesth. 2010;24(5):669–74.CrossRefPubMed
17.
go back to reference Koyama K, Kaneko I, Mori K: [The effect of indomethacin suppository in preventing mesenteric traction syndrome]. Masui 1995, 44(8):1131–1134. Koyama K, Kaneko I, Mori K: [The effect of indomethacin suppository in preventing mesenteric traction syndrome]. Masui 1995, 44(8):1131–1134.
18.
go back to reference Hudson JC, Wurm WH, O'Donnel TF Jr, Kane FR, Mackey WC, Su YF, Watkins WD. Ibuprofen pretreatment inhibits prostacyclin release during abdominal exploration in aortic surgery. Anesthesiology. 1990;72(3):443–9.CrossRefPubMed Hudson JC, Wurm WH, O'Donnel TF Jr, Kane FR, Mackey WC, Su YF, Watkins WD. Ibuprofen pretreatment inhibits prostacyclin release during abdominal exploration in aortic surgery. Anesthesiology. 1990;72(3):443–9.CrossRefPubMed
Metadata
Title
Therapeutic effects of flurbiprofen axetil on mesenteric traction syndrome: randomized clinical trial
Authors
Hidemasa Takahashi
Dai Shida
Kyoko Tagawa
Ryo Iwamoto
Makoto Arita
Hiroyuki Arai
Takeo Suzuki
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Surgery / Issue 1/2017
Electronic ISSN: 1471-2482
DOI
https://doi.org/10.1186/s12893-017-0286-y

Other articles of this Issue 1/2017

BMC Surgery 1/2017 Go to the issue